基于人工智能的纳米机器人向药物输送系统的审查,用于特定于大脑的向
Akriti Rai1, Kamal Shah2, Hitesh Kumar Dewangan3
1School of Pharmacy, Lingayas Vidyapeeth, Nachauli, Jasana Road, Faridabad, Haryana 121002, India.
Current pharmaceutical design
|December 19, 2023
概括
纳米技术,特别是纳米机器人,为通过血脑屏障 (BBB) 传递治疗药物以治疗神经系统疾病和脑癌提供了有前途的解决方案. 未来的研究重点是人工智能驱动的纳米机器人,以实现安全有效的BBB互动.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 神经科学是一个神经科学.
背景情况:
- 血脑屏障 (BBB) 在治疗神经系统疾病和脑癌症方面是一个重大挑战.
- 使用微流体和3D培养的体外模型对于研究BBB功能和神经药理学至关重要.
结论:
- 纳米机器人具有很大的潜力,可以促进神经疾病的治疗.
- 医疗保健专业人员,工程师,化学家和生物工程师之间的跨学科合作对于制药开发和神经学研究至关重要.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


